Healthcare & Pharmaceuticals Blog
- Blog: Haynes and Boone BlogsEMPLOYEE BENEFIT/EXECUTIVE COMPENSATION CHANGES MADE BY THE CARES ACTPosted on April 1, 2020 by Haynes and Boone Benefits GroupOn March 27, 2020, Congress passed the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). This historic $2 trillion relief package received bipartisan support and is part of the third wave of federal government support as the nation copes with the acute economic fallout from the coronavirus (COVID-19) pandemic. Some of the key […] The post EMPLOYEE BENEFIT/EXECUTIVE COMPENSATION CHANGES MADE BY THE CARES ACT appeared first on Haynes and Boone Blogs.
- Blog: ALTIUS BlogsReimbursement of medicinal products in times of pandemics and budgetary constraints: why quick fixes do not workPosted on April 1, 2020 by
- Blog: Biologics BlogThe FDA Regulatory Landscape for Covid-19 Treatments and VaccinesPosted on March 15, 2020 by As the United States and countries all over the world continue to grapple with the Covid-19 pandemic, the race is on for Covid-19 treatments and vaccines. There is currently no FDA-approved therapy or vaccine for Covid-19. Given the profound urgency, life sciences companies and other researchers are prioritizing research and development of potential therapies and [...]